참고문헌
- Collins AJ, Foley R, Herzog C, et al. Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis 2008;51(1 Suppl 1):S1-S320.
- Cooper WA, O'Brien SM, Thourani VH, et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation 2006;113:1063-1070. https://doi.org/10.1161/CIRCULATIONAHA.105.580084
- Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 2002;106:2207-2211. https://doi.org/10.1161/01.CIR.0000035248.71165.EB
- Aoki J, Ong AT, Hoye A, et al. Five year clinical effect of coronary stenting and coronary artery bypass grafting in renal insufficient patients with multivessel coronary artery disease: insights from ARTS trial. Eur Heart J 2005;26:1488-1493. https://doi.org/10.1093/eurheartj/ehi288
- Halkin A, Mehran R, Casey CW, et al. Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial. Am Heart J 2005;150:1163-1170. https://doi.org/10.1016/j.ahj.2005.01.032
- Javaid A, Steinberg DH, Buch AN, et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation 2007;116(11 Suppl):I200-I206.
- Ashrith G, Lee VV, Elayda MA, Reul RM, Wilson JM. Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease. Am J Cardiol 2010;106:348-353. https://doi.org/10.1016/j.amjcard.2010.03.037
- Widimsky P, Rychlik I. Renal disease and acute coronary syndrome. Heart 2010;96:86-92. https://doi.org/10.1136/hrt.2008.161034
- Shenoy C, Boura J, Orshaw P, Harjai KJ. Drug-eluting stents in patients with chronic kidney disease: a prospective registry study. PLoS One 2010;5:e15070. https://doi.org/10.1371/journal.pone.0015070
- Zhang RY, Ni JW, Zhang JS, et al. Long term clinical outcomes in patients with moderate renal insufficiency undergoing stent based percutaneous coronary intervention. Chin Med J (Engl) 2006;119:1176-1181.
- Appleby CE, Ivanov J, Lavi S, et al. The adverse long-term impact of renal impairment in patients undergoing percutaneous coronary intervention in the drug-eluting stent era. Circ Cardiovasc Interv 2009;2:309-316. https://doi.org/10.1161/CIRCINTERVENTIONS.108.828954
- Nakazawa G, Tanabe K, Aoki J, et al. Impact of renal insufficiency on clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents. Catheter Cardiovasc Interv 2007;69:808-814. https://doi.org/10.1002/ccd.21016
- Lasala JM, Cox DA, Dobies D, et al. Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries. Circ Cardiovasc Interv 2009;2:285-293. https://doi.org/10.1161/CIRCINTERVENTIONS.109.852178
- Okada T, Hayashi Y, Toyofuku M, et al. One-year clinical outcomes of dialysis patients after implantation with sirolimus-eluting coronary stents. Circ J 2008;72:1430-1435. https://doi.org/10.1253/circj.CJ-08-0010
- Bae EH, Lim SY, Choi YH, et al. Drug-eluting vs. bare-metal stents for treatment of acute myocardial infarction with renal insufficiency: results from Korea Acute Myocardial Infarction Registry. Circ J 2011;75:2798-2804. https://doi.org/10.1253/circj.CJ-11-0586
- Hachinohe D, Jeong MH, Saito S, et al. Comparison of drug-eluting stents in acute myocardial infarction patients with chronic kidney disease. Korean J Intern Med 2012;27:397-406. https://doi.org/10.3904/kjim.2012.27.4.397